⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for hpk1 inhibitor

Every month we try and update this database with for hpk1 inhibitor cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
PF-07265028 As Single Agent And In Combination With Sasanlimab in Advanced or Metastatic Solid TumorsNCT05233436
Advanced Solid ...
Gastric Cancer
Gastroesophagea...
Urothelial Canc...
Non Small Cell ...
Head and Neck S...
PF-07265028
Sasanlimab
18 Years - 99 YearsPfizer
PF-07265028 As Single Agent And In Combination With Sasanlimab in Advanced or Metastatic Solid TumorsNCT05233436
Advanced Solid ...
Gastric Cancer
Gastroesophagea...
Urothelial Canc...
Non Small Cell ...
Head and Neck S...
PF-07265028
Sasanlimab
18 Years - 99 YearsPfizer
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: